# Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.

- **DOI:** [10.3390/nu16101504](https://doi.org/10.3390/nu16101504)
- **Rating:** Sound (3.1 out of 5)
- **Verdict:** A competent multicentre diet-plus-supplement RCT showing curcumin and resveratrol add no benefit over a Mediterranean diet, undermined by the absence of any non-diet control arm.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-06-15
- **Evaluation page:** https://www.nabu.science/paper/10.3390%2Fnu16101504

## Strengths

- **Honest null finding on supplement add-on** By standardizing the Mediterranean diet across all three arms, the trial isolates the add-on question and reports that curcumin and resveratrol produced no broad between-group superiority. This narrows an interpretive ambiguity in prior supplement studies that lacked dietary control.
  - Dimension: contribution
  - Location: Results Tables 4–7; Discussion
- **Validated instruments and standardized measurement** The study uses disease-specific, validated outcome tools (Truelove-Witts Index, SF-36, IBDQ, MEDAS) and standardized anthropometry under ISAK guidelines performed by a single researcher. This strengthens measurement consistency across the two sites.
  - Dimension: methodological rigour
  - Location: Methods 2.4.2–2.4.9
- **Clear, well-organized reporting** The manuscript follows a conventional, readable structure and presents its core result pattern transparently across tables, making the comparative findings easy to follow.
  - Dimension: reporting
  - Location: Results §3; Tables 4–7

## Limitations

- **No non-diet control arm** All participants received the Mediterranean diet, so within-group improvements cannot be attributed to the intervention rather than natural disease course, regression to the mean, or concurrent medical treatment. This directly undercuts the conclusion that the diet is effective.
  - Dimension: methodological rigour
  - Location: Methods 2.2; Discussion
- **Conclusions overreach the design** The abstract and conclusions assert the Mediterranean diet is an effective and safe clinical-practice intervention, a causal and safety claim that an unblinded, controlled-only-against-supplements trial without systematic harms monitoring cannot support.
  - Dimension: reporting
  - Location: Abstract; Conclusions §5
- **Unblinded design with multiplicity risk** Subjective primary outcomes are assessed without blinding, raising performance and detection bias, and many within-group significance tests are reported without a pre-specified primary endpoint or global multiplicity correction. Together these weaken confidence in the positive within-group claims.
  - Dimension: methodological rigour
  - Location: Methods 2.2, 2.5; Results Tables 3–7

## Reliability checks

Caveats (3 of 4 checks).

- **Internal coherence:** Noted. Reported counts are internally consistent across abstract, methods, and results (48 enrolled, 46 analyzed), but the Abstract and Conclusions frame the Mediterranean diet as 'effective and safe' for clinical practice beyond what a design with no non-MD control can support, and numerous within-group significance tests are reported without a pre-specified primary endpoint or global multiplicity strategy.
- **Research conduct:** Noted. Ethics approval (KN: 2021/24-30122021), trial registration (NCT05761327), and informed consent are declared in Methods 2.1, which is positive, but registration timing relative to enrolment is not clarified in-text, no conflict-of-interest disclosure is visible despite a named supplement manufacturer, and no data or code availability statement is present.
- **Reference integrity:** Pending

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
